Severe asthma

Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program

Nizar N. Jarjour, Serpil C. Erzurum, Eugene R. Bleecker, William Calhoun, Mario Castro, Suzy A A Comhair, Kian Fan Chung, Douglas Curran-Everett, Raed A. Dweik, Sean B. Fain, Anne M. Fitzpatrick, Benjamin M. Gaston, Elliot Israel, Annette Hastie, Eric A. Hoffman, Fernando Holguin, Bruce D. Levy, Deborah A. Meyers, Wendy C. Moore, Stephen P. Peters & 4 others Ronald L. Sorkness, W. Gerald Teague, Sally E. Wenzel, William W. Busse

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, andcellular inflammatory features anduniquestructure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.

Original languageEnglish (US)
Pages (from-to)356-362
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume185
Issue number4
DOIs
StatePublished - Feb 15 2012

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Asthma
Research
Bronchoscopy
Molecular Biology

Keywords

  • Asthma
  • Bronchoscopy
  • Imaging
  • Inflammation
  • Remodeling

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Severe asthma : Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. / Jarjour, Nizar N.; Erzurum, Serpil C.; Bleecker, Eugene R.; Calhoun, William; Castro, Mario; Comhair, Suzy A A; Chung, Kian Fan; Curran-Everett, Douglas; Dweik, Raed A.; Fain, Sean B.; Fitzpatrick, Anne M.; Gaston, Benjamin M.; Israel, Elliot; Hastie, Annette; Hoffman, Eric A.; Holguin, Fernando; Levy, Bruce D.; Meyers, Deborah A.; Moore, Wendy C.; Peters, Stephen P.; Sorkness, Ronald L.; Teague, W. Gerald; Wenzel, Sally E.; Busse, William W.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 185, No. 4, 15.02.2012, p. 356-362.

Research output: Contribution to journalArticle

Jarjour, NN, Erzurum, SC, Bleecker, ER, Calhoun, W, Castro, M, Comhair, SAA, Chung, KF, Curran-Everett, D, Dweik, RA, Fain, SB, Fitzpatrick, AM, Gaston, BM, Israel, E, Hastie, A, Hoffman, EA, Holguin, F, Levy, BD, Meyers, DA, Moore, WC, Peters, SP, Sorkness, RL, Teague, WG, Wenzel, SE & Busse, WW 2012, 'Severe asthma: Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program', American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 4, pp. 356-362. https://doi.org/10.1164/rccm.201107-1317PP
Jarjour, Nizar N. ; Erzurum, Serpil C. ; Bleecker, Eugene R. ; Calhoun, William ; Castro, Mario ; Comhair, Suzy A A ; Chung, Kian Fan ; Curran-Everett, Douglas ; Dweik, Raed A. ; Fain, Sean B. ; Fitzpatrick, Anne M. ; Gaston, Benjamin M. ; Israel, Elliot ; Hastie, Annette ; Hoffman, Eric A. ; Holguin, Fernando ; Levy, Bruce D. ; Meyers, Deborah A. ; Moore, Wendy C. ; Peters, Stephen P. ; Sorkness, Ronald L. ; Teague, W. Gerald ; Wenzel, Sally E. ; Busse, William W. / Severe asthma : Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. In: American Journal of Respiratory and Critical Care Medicine. 2012 ; Vol. 185, No. 4. pp. 356-362.
@article{cc911f54eef44b14b384d2d2c2553298,
title = "Severe asthma: Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program",
abstract = "The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, andcellular inflammatory features anduniquestructure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.",
keywords = "Asthma, Bronchoscopy, Imaging, Inflammation, Remodeling",
author = "Jarjour, {Nizar N.} and Erzurum, {Serpil C.} and Bleecker, {Eugene R.} and William Calhoun and Mario Castro and Comhair, {Suzy A A} and Chung, {Kian Fan} and Douglas Curran-Everett and Dweik, {Raed A.} and Fain, {Sean B.} and Fitzpatrick, {Anne M.} and Gaston, {Benjamin M.} and Elliot Israel and Annette Hastie and Hoffman, {Eric A.} and Fernando Holguin and Levy, {Bruce D.} and Meyers, {Deborah A.} and Moore, {Wendy C.} and Peters, {Stephen P.} and Sorkness, {Ronald L.} and Teague, {W. Gerald} and Wenzel, {Sally E.} and Busse, {William W.}",
year = "2012",
month = "2",
day = "15",
doi = "10.1164/rccm.201107-1317PP",
language = "English (US)",
volume = "185",
pages = "356--362",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Severe asthma

T2 - Lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program

AU - Jarjour, Nizar N.

AU - Erzurum, Serpil C.

AU - Bleecker, Eugene R.

AU - Calhoun, William

AU - Castro, Mario

AU - Comhair, Suzy A A

AU - Chung, Kian Fan

AU - Curran-Everett, Douglas

AU - Dweik, Raed A.

AU - Fain, Sean B.

AU - Fitzpatrick, Anne M.

AU - Gaston, Benjamin M.

AU - Israel, Elliot

AU - Hastie, Annette

AU - Hoffman, Eric A.

AU - Holguin, Fernando

AU - Levy, Bruce D.

AU - Meyers, Deborah A.

AU - Moore, Wendy C.

AU - Peters, Stephen P.

AU - Sorkness, Ronald L.

AU - Teague, W. Gerald

AU - Wenzel, Sally E.

AU - Busse, William W.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, andcellular inflammatory features anduniquestructure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.

AB - The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, andcellular inflammatory features anduniquestructure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.

KW - Asthma

KW - Bronchoscopy

KW - Imaging

KW - Inflammation

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=84857410928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857410928&partnerID=8YFLogxK

U2 - 10.1164/rccm.201107-1317PP

DO - 10.1164/rccm.201107-1317PP

M3 - Article

VL - 185

SP - 356

EP - 362

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -